These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6348173)

  • 21. Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.
    Mizutani Y; Bonavida B; Nio Y; Yoshida O
    Cancer; 1993 Feb; 71(4):1313-21. PubMed ID: 7679609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
    Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
    Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization and utilization of a monoclonal antibody inhibiting porcine natural killer cell activity for isolation of natural killer and killer cells.
    Dato ME; Kim YB
    J Immunol; 1990 Jun; 144(11):4452-62. PubMed ID: 1971298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A large subpopulation of lymphocytes with T helper phenotype (Leu-3/T4+) exhibits the property of binding to NK cell targets and granular lymphocyte morphology.
    Velardi A; Grossi CE; Cooper MD
    J Immunol; 1985 Jan; 134(1):58-64. PubMed ID: 3155472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recruitment of OKM1 staining lymphocytes with selective binding to K-562 tumour targets by interferon.
    Salata RA; Schacter BZ; Ellner JJ
    Clin Exp Immunol; 1983 Apr; 52(1):185-90. PubMed ID: 6190593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of cytotoxicity in human peripheral blood mononuclear cells by monoclonal antibody OKT3.
    Jung G; Martin DE; Müller-Eberhard HJ
    J Immunol; 1987 Jul; 139(2):639-44. PubMed ID: 3110277
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased NK activity in hairy cell leukemia (HCL): an analysis at the cellular level.
    Fontana L; De Rossi G; De Sanctis G; Ensoli F; Lopez M; Annino L; Mandelli F
    Blut; 1986 Aug; 53(2):107-13. PubMed ID: 3730622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
    Grimm EA; Ramsey KM; Mazumder A; Wilson DJ; Djeu JY; Rosenberg SA
    J Exp Med; 1983 Mar; 157(3):884-97. PubMed ID: 6601174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell inhibition of young spherules and endospores of Coccidioides immitis.
    Petkus AF; Baum LL
    J Immunol; 1987 Nov; 139(9):3107-11. PubMed ID: 2444651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The skin test antigen stimulated killer (STAK) cell mediating NK like CMC is OKM1 positive and OKT3 negative.
    Tartof D; Curran JJ; Levitt D; Loken MR
    Clin Exp Immunol; 1983 Nov; 54(2):561-6. PubMed ID: 6360439
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The membrane phenotype of in vivo induced tumor selective cytolytic lymphocytes of the rat: a distinction from NK cells.
    Hedlund G; Sjögren HO
    Cell Immunol; 1986 Jun; 100(1):232-8. PubMed ID: 3742601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different human hematopoetic cell lines, susceptible or resistant to NK lysis, conjugate identically to non-adherent peripheral blood lymphocytes.
    Ullberg M; Jondal M
    J Clin Lab Immunol; 1982 Dec; 9(3):177-83. PubMed ID: 7166750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoclonal antibodies which distinguish between human NK cells and cytotoxic T lymphocytes.
    Zarling JM; Kung PC
    Nature; 1980 Nov; 288(5789):394-6. PubMed ID: 6968872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and functional characterization of monoclonal antibodies recognizing chicken lymphocytes with natural killer cell activity.
    Chung KS; Lillehoj HS
    Vet Immunol Immunopathol; 1991 Jul; 28(3-4):351-63. PubMed ID: 1659030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
    J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.
    Hercend T; Griffin JD; Bensussan A; Schmidt RE; Edson MA; Brennan A; Murray C; Daley JF; Schlossman SF; Ritz J
    J Clin Invest; 1985 Mar; 75(3):932-43. PubMed ID: 3884668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells.
    Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM
    Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.